Wei, A. H., Döhner, H., Sayar, H., Ravandi, F., Montesinos, P., Dombret, H., Selleslag, D., Porkka, K., Jang, J., Skikne, B., Beach, C. L., Prebet, T., Zhang, G., Risueño, A., Ugidos, M., See, W. L., Menezes, D., & Roboz, G. J. (2023). long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial. American journal of hematology, 98(4), E84–E87. http://access.bl.uk/ark:/81055/vdc_100181731187.0x000041